Insulin aspart, recombinant Subcutaneous and Pentasa Rectal
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pentasa Rectal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Pentasa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pentazocine
- Insulin aspart, recombinant Subcutaneous-Pentazocine Acetaminophen
- Insulin aspart, recombinant Subcutaneous-Pentazocine and Naloxone
- Insulin aspart, recombinant Subcutaneous-Pentazocine Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Pentazocine Injection
- Insulin aspart, recombinant Subcutaneous-Pentazocine Lactate
- Pentasa Rectal-Insulin degludec
- Pentasa Rectal-Insulin Degludec (U-100) Prefilled Pens
- Pentasa Rectal-Insulin Degludec (U-100) Vials
- Pentasa Rectal-Insulin Degludec (U-200) Prefilled Pens
- Pentasa Rectal-Insulin degludec and liraglutide
- Pentasa Rectal-Insulin degludec and liraglutide Subcutaneous